SEARCH RESULTS

341187 RESULTS

Beyond Antibodies: From CTAD, New Attempts at Outflanking Alzheimer’s

CONFERENCE COVERAGE 2024-11-22 Conference Coverage Most Alzheimerologists agree that lecanemab and donanemab are a start, but insufficient to treat this disease. At the Clinical Trials in Alzheimer’s Disease conference, held last month in Madrid, scientists not only debated how to make

Jeremy Ford


Massachusetts General Hospital
Boston, United States

Current Filters

No filters selected

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE